Authors: Lafeuillade, A Poggi, C Chadapaud, S Hittinger, G Chouraqui, M Delbeke, E

Citation: A. Lafeuillade et al., HIV-1 induction-maintenance at the lymph node level: The "Apollo-97" study, J ACQ IMM D, 28(2), 2001, pp. 154-157

Authors: Lafeuillade, A Halfon, P Chadapaud, S Hittinger, G Khiri, H Poggi, C

Citation: A. Lafeuillade et al., Potential adverse effects of structured therapeutic interruptions on the pool of HIV-infected cells, J ACQ IMM D, 28(2), 2001, pp. 197-199

Authors: Lafeuillade, A Poggi, C Chadapaud, S Hittinger, G Chouraqui, M Pisapia, M Delbeke, E

Citation: A. Lafeuillade et al., Pilot study of a combination of highly active antiretroviral therapy and cytokines to induce HIV-1 remission, J ACQ IMM D, 26(1), 2001, pp. 44-55

Authors: Lafeuillade, A Khiri, H Chadapaud, S Hittinger, G Halfon, P

Citation: A. Lafeuillade et al., Persistence of HIV-1 resistance in lymph node mononuclear cell RNA despiteeffective HAART, AIDS, 15(15), 2001, pp. 1965-1969

Authors: Lafeuillade, A Hittinger, G Chadapaud, S

Citation: A. Lafeuillade et al., Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection, LANCET, 357(9252), 2001, pp. 280-281